| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | Chief Scientific Officer | $147K | Apr 23, 2025 | ||
| ZVSA | ZyVersa Therapeutics, Inc. | Director | Jan 6, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|